Amazon to spin up a secretive lab focused on cancer research
Category: #health  By Ojaswita Kutepatil  Date: 2018-06-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

Amazon to spin up a secretive lab focused on cancer research

Following its entry into the healthcare realm, the e-commerce behemoth Amazon has been recently found leading a secretive research group called Grand Challenge. The group, led by the creator of Google Glass is reportedly working on medical records, cancer research, and last-mile delivery that could eventually expand the tech giant’s footprint beyond e-commerce, hardware, and Amazon Web Services.

Sources familiar with the matter reveal that one of the important initiatives Amazon will be focusing on is applying machine learning to cancer research. The company will partner with Fred Hutchinson Cancer Research Center, which is located close to Amazon’s headquarters in Seattle.

A Fred Hutch spokesperson was reported saying that the research centers have several projects underway with industry magnates including Tableau, Microsoft, and Amazon. He further added that they don’t have any specific Amazon Web Services projects to preview currently but hopefully may have some later this year. 

According to reliable reports, the secretive Amazon group, also called Amazon X and 1492, is pitching a health venture named as Hera to the health insurance companies. For the record, Grand Challenge is a part of Amazon Web Services and has been developing Hera for three years. The conjoint work is said to use e-records and identify a patient’s possible misdiagnosis. The reports further claim that the technology could do in-depth analysis and might help an insurance company remove inaccurate data to better assess risk.

For the uninitiated, Grand Challenge is run by the creator of Google Glass and former Google employee Babak Parviz, and is designed similar to the original Google X moonshots lab, a subsidiary of Alphabet which was known as X.

In other news, it has been reported that Amazon, Berkshire Hathaway, and JP Morgan Chase & Co. had announced plans in January to form an independent healthcare company that will focus initially on emerging technologies that will serve their US-based employees.



About Author

Ojaswita Kutepatil

Email: [email protected]   

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, presently develops content for Market Size Forecasters, Algosonline, and other similar platforms. Having had a prior experience in Business Development and Technical Engineering, she now pens down articles pe...

Read More

More News By Ojaswita Kutepatil

Pepperfry to pump $12M in expansion & boost supply chain operations
Pepperfry to pump $12M in expansion & boost supply chain operations
By Ojaswita Kutepatil

The Mumbai-based online retailer also looks to step into areas like augmented/virtual reality to advance shopping experience.

Pepperfry, the online furniture & ...

Dream Incubator leads health-tech firm NIRAMAI’s Series A funding
Dream Incubator leads health-tech firm NIRAMAI’s Series A funding
By Ojaswita Kutepatil

NIRAMAI Health Analytix Pvt. Ltd., the Bengaluru-based breast cancer screening start-up, has reportedly raised around $6 million in Series A investment round that was led by Dream Incubator, a management consulting fir...

Levi Strauss plans share market comeback after more than 3 decades
Levi Strauss plans share market comeback after more than 3 decades
By Ojaswita Kutepatil

In a recent turn of events, renowned Jeans manufacturer Levi Strauss & Co has reportedly filed documents for getting listed on the New York Stock Exchange, on the lookout for returning to public markets after over ...